iZafe Group AB (publ) (STO:IZAFE.B)
Sweden · Delayed Price · Currency is SEK 0.4040
-0.0080 (-1.94%)
Mar 5, 2026, 12:35 PM CET
iZafe Group AB Revenue
In the year 2025, iZafe Group AB had annual revenue of 5.99M SEK, down -24.68%. iZafe Group AB had revenue of 2.44M in the quarter ending December 31, 2025, with 3.84% growth.
Revenue
5.99M
Revenue Growth
-24.68%
P/S Ratio
26.91
Revenue / Employee
599.10K
Employees
10
Market Cap
161.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.99M | -1.96M | -24.68% |
| Dec 31, 2024 | 7.95M | 6.13M | 336.55% |
| Dec 31, 2023 | 1.82M | 1.09M | 149.93% |
| Dec 31, 2022 | 729.00K | 287.00K | 64.93% |
| Dec 31, 2021 | 442.00K | -9.05M | -95.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| Boule Diagnostics AB | 489.70M |
| Magle Chemoswed Holding AB | 300.49M |
| Subgen AI AB | 228.08M |
| Physitrack | 146.31M |